secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2023-12-01T23:59:59+00:00
Accession:  0000950170-23-067364
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix names Massimo Calafiore as President and CEO; Burzić not standing for re-election
--------------------------------------------------------------------------------

- Massimo Calafiore appointed President and CEO effective early 2024, following LimaCorporate's acquisition by Enovis.
- Calafiore receives $825k base salary, 110% target bonus, and $7.5M in equity inducement awards (50% performance RSUs, 25% options, 25% time RSUs).
- He will receive a $225k after-tax relocation payment to San Diego area.
- Interim CEO Catherine Burzić will not stand for re-election at 2024 Annual Meeting; remains Chair until then.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000095017023067364/0000950170-23-067364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000095017023067364/ofix-20231127.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-067364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer